LinkedIn Pixel Increase Access to the Diabetes Eye Exam with LumineticsCore - Digital Diagnostics

Increase Access to the Diabetes Eye Exam with LumineticsCore®

Diagnose diabetic retinopathy at the point-of-care. AI-powered, FDA-cleared, and seamlessly integrated into your practice to close the care gap and transform diabetes care.

Watch 40-Second How it Works Video

Note: Your privacy is important to us. We will never send spam or share your information.

Why Watch the Demo?

AI-powered, FDA-cleared, and seamlessly integrated into your practice to close the care gap and transform diabetes care.

  • Check Mark Icon Diagnose diabetic retinopathy at the point-of-care
  • Check Mark Icon Exams completed in minutes during the patient visit
  • Check Mark Icon Reimbursable under CPT 92229
  • Check Mark Icon Backed by real-world results in primary care
Real-World Results with FDA-Cleared AI

One Diagnosis. One Visit. A Life-Changing Impact.

Closing the eye exam for diabetes care gap isn’t just about metrics. It’s about people.

“I really loved being able to see the results of the LumineticsCore exam right away. They printed a picture for me [and] I could ask questions based on what I saw.”

– Jessica Ching, LumineticsCore patient

Jessica Ching, a LumineticsCore patient, smiling while seated at a table in a modern office with teal walls and framed eye artwork in the background.

Why LumineticsCore?

  • Diagnostic results in real time at the point-of-care Diagnostic results in real time at the point-of-care
  • No need for specialist overread or telemedicine call backs No need for specialist overread or telemedicine call backs
  • Algorithm diagnoses within 30 seconds of image submission Algorithm diagnoses within 30 seconds of image submission
  • Closes HEDIS care gap Closes HEDIS care gap
  • Reimbursable with CPT Code 92229 Reimbursable with CPT Code 92229

LumineticsCore Patient Benefits

Increase patient access to a specialty diagnosis

Increase patient access to a specialty diagnosis

Diagnosis and referral are done during the initial patient visit

Diagnosis and referral are done during the initial patient visit

No telemedicine callbacks are needed

No telemedicine callbacks are needed

Learn More About LumineticsCore

What is LumineticsCore?

LumineticsCore is the first FDA-cleared autonomous Al diagnostic platform, capable of making a diagnosis without physician input. This groundbreaking system detects diabetic retinopathy at the point-of-care, providing immediate results and facilitating timely interventions. The implementation of LumineticsCore has led to significant improvements in patient outcomes, including Zufall Community Health Centers, where adherence rates for the eye exam for diabetes increased from 12% to 30% after the system’s integration. Similarly, at Cahaba Medical Care, within 90 days, LumineticsCore diagnosed diabetic retinopathy in more than 1 out of every 4 patients tested, cases that could have otherwise gone undetected.

How is LumineticsCore from Digital Diagnostics different from other diabetic retinal exam services?

LumineticsCore is the only fully autonomous Al diagnostic system to be De Novo cleared by the FDA. LumineticsCore is installed in point-of-care settings to increase access for patients by producing rapid diagnostic results that do not require physician overread. By integrating autonomous Al diagnostics into clinical practice, Digital Diagnostics addresses critical barriers in healthcare, such as limited access to specialists and the need for timely disease detection. These solutions not only improve patient outcomes but also enhance healthcare productivity by streamlining diagnostic processes and allowing healthcare providers to focus on patient care.

What is the difference between autonomous Al and assistive AI?

Assistive Al is designed to augment human decision-making. In other words, it helps, or assists, humans in making better decisions, faster. In healthcare, assistive Al typically serves as a valuable support tool for medical professionals, aiding in tasks such as evaluating large datasets, taking measurements, and analyzing medical images. Autonomous Al, which functions without direct human supervision, involves the technology making decisions on its own. Additionally, autonomous Al systems can be trained to consider a wide variety of potential outcomes to help reduce bias. As it relates to healthcare, autonomous Al applications are being used to provide medical diagnoses without the need for human interpretation.

Watch Video - Integrate LumineticsCore® into your practice.
Watch Video

Integrate LumineticsCore®
into your practice.